SheetalShroffMD

Neurology • Houston, TX

Neuromuscular Medicine

Neuromuscular fellowship program director Assistant Professor of Clinical Neurology Houston Methodist Neurological Institute Weill Cornell Medical College

Join to view full profile

Dr. Shroff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shroff's full profile

Already have an account?

Office
6560 Fannin Street
Suite 802
Houston, TX 77030
Phone+1 713-363-7310

Fax+1 713-790-2059

Summary

Sheetal Shroff, MD, is a Neurologist based in Houston, TX, with a subspecialty in Neuromuscular Medicine. She completed her education and residencies at the University of Texas Medical Branch Hospitals and her fellowship at Methodist Hospital in Houston. She is presently employed as an Assistant Professor at Houston Methodist Hospital since 2014. Her areas of expertise include treatment of amyotrophic lateral sclerosis, myasthenia gravis, electromyography, muscle biopsy, and myotonic dystrophy. She is also an accomplished researcher and author, with several publications cited multiple times in her field. Additionally, she has participated in several clinical trials.

Education & Training

Methodist Hospital (Houston)Fellowship, Neuromuscular Medicine (Neurology), 2014 - 2015
University of Texas Medical Branch HospitalsResidency, Neurology, 2011 - 2014
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2010 - 2011
Kempegowda Institute of Medical ScienceClass of 2007

Certifications & Licensure

TX State Medical License 2014 - 2024
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
American Board of Electridiagnostic MedicineABEM (EMG/NCS)

Clinical Trials

HEALEY ALS Platform Trial - Master Protocol Start of enrollment: 2020 Jul 14
Active, not recruiting
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen G DNL343 Start of enrollment: 2023 May 24
Enrolling by invitation
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262 Start of enrollment: 2023 Mar 23
Enrolling by invitation
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose Start of enrollment: 2022 Feb 21
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen D Pridopidine Start of enrollment: 2020 Dec 18
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen C CNM-Au8 Start of enrollment: 2020 Jul 30
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen A Zilucoplan Start of enrollment: 2020 Jul 29
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen B Verdiperstat Start of enrollment: 2020 Jul 28
Completed
Phase 2, Phase 3
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) Start of enrollment: 2019 Dec 04
Recruiting
Phase 2
A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis Start of enrollment: 2021 Feb 03
Completed
Phase 3
Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis Start of enrollment: 2022 Jun 27
Recruiting
Phase 3
Study of Safety and of the Mechanism of BLZ945 in ALS Patients Start of enrollment: 2019 Dec 30
Recruiting
Phase 2
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis Start of enrollment: 2024 Aug 01
Recruiting
Phase 1, Phase 2
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM Start of enrollment: 2024 Jan 11
Recruiting
Phase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) Start of enrollment: 2023 Dec 13
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

44 citations
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Vera Bril, Artur Drużdż, Julian Grosskreutz, Ali A Habib, Renato Mantegazza
The Lancet. Neurology. 2023-05-01
9 citations
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis.
Melanie Quintana, Benjamin R Saville, Matteo Vestrucci, Michelle A Detry, Lori Chibnik
Annals of Neurology. 2023-09-01
78 citations
Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis.
Karen Hewett, Donald B. Sanders, Richard A. Grove, Christine L. Broderick, Todd J. Rudo
Neurology. 2018-04-17

Press Mentions

Rare Side Effect of Flu Puts Young Men at RiskMarch 1st, 2018

Professional Memberships

Other Languages

Kannada, Hindi